相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic
Leiluo Geng et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
Julien Bricambert et al.
NATURE COMMUNICATIONS (2018)
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso et al.
GASTROENTEROLOGY (2017)
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
Annika S. Axelsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
Gabsik Yang et al.
SCIENTIFIC REPORTS (2016)
Nonalcoholic Fatty Liver Disease A Systematic Review
Mary E. Rinella
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
Kook Hwan Kim et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Sulforaphane-rich broccoli sprout extract improves hepatic abnormalities in male subjects
Masahiro Kikuchi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress
Seong Hun Kim et al.
DIABETOLOGIA (2015)
FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling
Francesc Ribas et al.
BIOCHEMICAL JOURNAL (2014)
Sulforaphane induces Nrf2 and protects against CYP2E1-dependent binge alcohol-induced liver steatosis
Richard Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
Sulforaphane attenuates obesity by inhibiting adipogenesis and activating the AMPK pathway in obese mice
Kyeong-Mi Choi et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Fibroblast growth factor 21 is induced by endoplasmic reticulum stress
Frank G. Schaap et al.
BIOCHIMIE (2013)
Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones
Andrew C. Adams et al.
MOLECULAR METABOLISM (2013)
Understanding the Physical Interactions in the FGF21/FGFR/β-Klotho Complex: Structural Requirements and Implications in FGF21 Signaling
Junming Yie et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice
Jialin Xu et al.
DIABETES (2012)
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis
Ffolliott M. Fisher et al.
GENES & DEVELOPMENT (2012)
Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial
Zahra Bahadoran et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2012)
A call for transparent reporting to optimize the predictive value of preclinical research
Story C. Landis et al.
NATURE (2012)
Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons
Marcelo O. Dietrich et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease
Susan Kralisch et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2011)
Nrf2 Represses FGF21 During Long-Term High-Fat Diet-Induced Obesity in Mice
Dionysios V. Chartoumpekis et al.
DIABETES (2011)
Current therapeutic strategies in non-alcoholic fatty liver disease
J. K. Dowman et al.
DIABETES OBESITY & METABOLISM (2011)
Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity
J. Jager et al.
DIABETOLOGIA (2011)
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Elayne Hondares et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study
Hongmei Yan et al.
PLOS ONE (2011)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss
Michael K. Badman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Jing Xu et al.
DIABETES (2009)
Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
Michael K. Badman et al.
ENDOCRINOLOGY (2009)
Different Roles of N- and C-Termini in the Functional Activity of FGF21
Radmila Micanovic et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
Ivana Dostalova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor γ and altered metabolic states
Eric S. Muise et al.
MOLECULAR PHARMACOLOGY (2008)
p38 mitogen-activated protein kinase plays a stimulatory role in hepatic gluconeogenesis
WH Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
分享论文
